Opendata, web and dolomites

Cancer-Targeted PolyIC

Treatment of EGFR over-expressing cancers by targeted non-viral delivery of PolyIC

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 Cancer-Targeted PolyIC project word cloud

Explore the words cloud of the Cancer-Targeted PolyIC project. It provides you a very rough idea of what is the project "Cancer-Targeted PolyIC" about.

virus    pic    deadly    2011    2012    last    commercialization    interferons    ifn    bystander    et    half    therapy    fund    double    frequently    models    spread    company    preventing    interferon    egfr    shaffert    anti    resembling    agents    selective    egf    polyethylenimine    mda    simultaneously    family    orthotropic    capitalist    al    rna    468    overexpressing    proliferative    infected    translated    simplified    poly    eliminated    apoptotic    mechanisms    antiproliferative    overexpress    synthetic    thereby    expressed    polyethyleneglycol    melittin    shown    vectors    activates    cells    kill    metastatic    delivered    mppe    venture    iosine    cancer    subcutaneous    efficient    shir    cytokines    glioblastoma    cancers    dsrna    least    adenocarcinoma    breast    stranded    abourbeh    disseminated    viruses    induce    expression    a431    impressive    cytosine    ready    mediated    pro    homing    heterogeneous    clinical    wtegfr    tumors    entities    2006    local    mb    systemic    u87mgwtegfr   

Project "Cancer-Targeted PolyIC" data sheet

The following table provides information about the project.

Coordinator
THE HEBREW UNIVERSITY OF JERUSALEM 

Organization address
address: EDMOND J SAFRA CAMPUS GIVAT RAM
city: JERUSALEM
postcode: 91904
website: www.huji.ac.il

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Israel [IL]
 Total cost 150˙000 €
 EC max contribution 150˙000 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2014-PoC
 Funding Scheme ERC-POC
 Starting year 2015
 Duration (year-month-day) from 2015-02-01   to  2016-07-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    THE HEBREW UNIVERSITY OF JERUSALEM IL (JERUSALEM) coordinator 150˙000.00

Map

 Project objective

We have recently shown that application of EGFR targeted synthetic dsRNA: Poly Iosine/Poly Cytosine (pIC) is highly efficient and selective against deadly cancers overexpressing EGFR, like glioblastoma (U87MGwtEGFR), breast cancer (MDA-MB-468) and adenocarcinoma (A431). Double-stranded RNA, frequently expressed in cells infected with viruses, activates a number of pro-apoptotic processes simultaneously. These dsRNA-induced mechanisms efficiently kill infected cells and induce expression of anti-proliferative cytokines from the interferon (IFN) family, thereby preventing spread of the virus. pIC delivered with Melittin-polyethylenimine-polyethyleneglycol-EGF (MPPE) eliminated orthotropic and subcutaneous tumors of the above cancers. Heterogeneous glioblastoma models where only half of the cells overexpress wtEGFR are also eliminated by local application, most likely due to a bystander antiproliferative effects, at least partially mediated by interferons (Shir et al., 2006). Systemic application of EGFR targeted pIC is also highly effective against breast and adenocarcinoma disseminated cancer models resembling metastatic cancers (Shir et al., 2011). During the last two years we have improved the vectors homing to EGFR to entities that can now be translated into clinical agents (Shaffert, 2011; Shir 2011, Abourbeh 2012). The impressive results with these more simplified vectors, make this project ready for clinical development, which requires fund raising from a Company/Venture capitalist. Commercialization of the therapy will be detailed in the proposal.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CANCER-TARGETED POLYIC" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "CANCER-TARGETED POLYIC" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

DISINTEGRATION (2019)

The Mass Politics of Disintegration

Read More  

PROGRESS (2019)

The Enemy of the Good: Towards a Theory of Moral Progress

Read More  

SUExp (2018)

Strategic Uncertainty: An Experimental Investigation

Read More